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Although T cell memory is generally thought to
require direct antigen exposure, we found an abun-
dance of memory-phenotype cells (20%–90%, aver-
aging over 50%) of CD4+ T cells specific to viral
antigens in adults who had never been infected.
These cells express the appropriate memory
markers and genes, rapidly produce cytokines, and
have clonally expanded. In contrast, the same T cell
receptor (TCR) specificities in newborns are almost
entirely naı¨ve, which might explain the vulnerability
of young children to infections. One mechanism
for this phenomenon is TCR cross-reactivity to
environmental antigens, and in support of this, we
found extensive cross-recognition by HIV-1 and
influenza-reactive T lymphocytes to other microbial
peptides and expansion of one of these after in-
fluenza vaccination. Thus, the presence of these
memory-phenotype T cells has significant implica-
tions for immunity to novel pathogens, child and
adult health, and the influence of pathogen-rich
versus hygienic environments.
INTRODUCTION
It is well known that memory T and B cells are critical for the
most rapid and efficacious immune responses (Jameson and
Masopust, 2009). In contrast, naı¨ve T cells can take a few days
to over a week to mount a response (Flynn et al., 1998). Thus,
a principal goal of vaccine development is to trigger memory
T cells, along with B cells and long-lived plasma cells, specific
to particular pathogens. Although it has been thought that direct
antigenic exposure is required for the formation of memory cells,
recent work on CD8+ T cell precursors in mice has found that
memory-phenotype cells can also develop without specific
exposure to their cognate antigen (Akue et al., 2012; Decman
et al., 2012; Haluszczak et al., 2009; Rudd et al., 2011). These
cells are thought to have developed their memory phenotype
through homeostatic signals mediated via interactions betweenself-peptides and the major histocompatibility complex (MHC).
Other mechanisms, such as T cell activation through T cell
receptor (TCR) cross-recognition of alternate ligand(s), might
also be involved.
Recently, enrichment techniques combined with peptide-
MHC (pMHC) tetramer staining have allowed the direct analysis
of the T cell repertoire, including cells that represent the preim-
mune repertoire, to an unprecedented degree (Moon et al.,
2007). This has resulted in a wealth of information about the
frequency of preimmune T cells in mice and growing evidence
that the T cell response is directly proportional to the antigen-
specific naı¨ve T cell pool (Kwok et al., 2012; Moon et al., 2007;
Obar et al., 2008). However, far less is known about the human
T cell repertoire at baseline, particularly pertaining to CD4+
T cells. Thus, we set out to comprehensively characterize the
adult human CD4+ T cell repertoire by using HLA-DR4 (DRA,
DRB1*0401)-restricted epitopes and pMHC tetramer enrichment
to examine the frequency and phenotype of precursor T cells
recognizing self-antigens or microbial epitopes in exposed or
unexposed individuals.
We found that for almost all the unexposed specificities
surveyed, our pMHC tetramers detected frequencies in a fairly
narrow range between one and ten cells per million CD4+
T cells in 26 adult blood-bank donors aged 28–80+ years.
Surprisingly, T cells stained for tetramers derived from HIV-1,
cytomegalovirus (CMV), and herpes simplex virus (HSV)
epitopes often had a very high proportion of memory-phenotype
cells—up to 93% (on average over 50%) in individuals who had
never been infected with these viruses. These cells not only had
memory surface markers, but they also expressed memory-
associated genes, exhibited rapid cytokine production, and
showed evidence of clonal expansion. Thus, they have many
of the expected characteristics of memory T cells and could offer
survival advantage in the event of a cognate infection. In this
context, it seems particularly notable that at least some of these
specificities are present in the umbilical blood cells of newborns,
but the fact that virtually all of them are of the naı¨ve phenotype
might partially explain the vulnerability of young children to
infectious diseases.
With respect to how these memory-phenotype T cells
are acquired, one possibility is homeostatic proliferation, during
which proliferating lymphocytes can acquire the characteris-
tics of memory (Sprent and Surh, 2011). Another possibility isImmunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc. 373
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Figure 1. Enrichment Based on Class II pMHC Tetramers Is Highly Sensitive and Specific
(A) HLA-DR4+ CD4+ lymphocytes were used as is or were spiked into HLA-DR4 lymphocytes for the achievement of 50- and 100-fold dilutions in a total of 55
million CD4+ T cells. Undiluted HLA-DR4 lymphocytes were used as a negative control. PB1 tetramer staining and enrichment were performed in parallel. Data
are representative of one individual from two independent experiments.
(B) A gp100-specific clone from single-cell expansion retained staining with gp100 tetramers, but not with HIV-1 tetramers. IFN-g was produced in response to
stimulation by gp100 peptide and gp100 protein, but not to a control HIV-1 peptide. Data are representative of two gp100-specific clones.
(C) Table showing T cell clones generated by expansion of single cells and labeled with gp100, HIV-1, HA, or tetanus tetramers. The percentage of cells that
retained staining with the same tetramer (%Tet+) was calculated by the division of the number of tetramer-positive clones by the total number of clones generated
for each specificity (see also Figure S1).
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CD4+ Memory-Phenotype T Cells in Unexposed Adultscross-reactivity with the many antigens in the environment,
especially given the myriad organisms that humans and other
species can be exposed to. In this context, it is well known
that ab TCRs have a strong propensity to be cross-reactive to
different pMHCs, most likely because of their flexible binding
sites (Newell et al., 2011; Reinherz et al., 1999; Reiser et al.,
2003). Consistent with this possibility, these memory-phenotype
cells exhibited extensive cross-reactivity to similar peptides
derived from other microbial genomes. Furthermore, we used
a seasonal influenza vaccine to directly show that immunization
with the 2009 H1N1 influenza strain can stimulate T cells specific
to a cross-reactive bacterial ortholog. Thus, cross-reactivity to
environmental antigens could be a major mechanism in eliciting
populations of memory T cells for infectious diseases that an
individual has not yet encountered.
RESULTS
Staining and Enrichment of Class II pMHC Tetramers
How well class II pMHC tetramers can identify rare unprimed
T cells in humans has been unclear, and we therefore first
explored the technical limits of using this approach to analyze
the naı¨ve human T cell repertoire. HLA-DR4 tetramers against
a conserved epitope from the PB1 protein of the influenza virus374 Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc.were generated and used for measuring the recovery of a known
number of PB1-specific lymphocytes spiked into HLA-DR4
background cells (Day et al., 2003). Using this approach, we
found more than 70% concordance between the numbers of
cells captured experimentally and what was expected (Fig-
ure 1A). These tetramer-labeled cells were clonally restricted to
Vb2 expression and could be detected in diluted samples con-
taining as few as three per ten million PB1-specific T cells (Fig-
ure 1A and Figure S1, available online).
To validate the specificity of this method with another
tetramer, we also stained peripheral-blood mononuclear cells
(PBMCs) from an HLA-DR4+ blood donor with a peptide
derived from the self-protein, gp100. Tetramer-positive clones
were generated, and 76% (35/46) of these retained staining
with gp100 tetramers. These clones responded to the gp100
peptide and recombinant gp100 protein, but not to a control
HIV-1 peptide, by interferon-g (IFN-g) production (Figure 1B).
Clones recognizing additional specificities from HIV-1, tetanus
toxin, and influenza virus were also generated, and 55%–
100% of those clones that grew retained staining with the
same tetramer used initially (Figure 1C). Taken together, these
data indicate that tetramer binding is specific and can identify
antigen-specific T cells with a sensitivity of one cell in several
million.
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Figure 2. Frequency Analysis of the Human
Antigen-Specific CD4+ Lymphocytes
All blood samples were obtained from individuals
seronegative for HIV and CMV exposures. HSV
exposure is as indicated (naı¨ve versus exposed).
(A) Frequencies of tetramer-tagged cells per
million CD4+ T cells. Each symbol represents an
antigen-specific population from one individual,
and the bar indicates the mean of experiments
performed independently with blood obtained at
different times.
(B) Comparison between T cells recognizing
a novel foreign antigen (pre: HIV-1, CMV, and
HSV-naı¨ve), exposed foreign antigen (post: Flu,
tetanus, and HSV-exposed), and self-antigen (self:
Fib, gp100, and PPins). The figure summarizes
data from all 26 individuals.
(C) Precursor frequencies of self-specific lym-
phocytes that recognized gp100, Fib, or PPins in
people ages <40 years (n = 7), 40–60 years (n = 13),
and >60 years (n = 6).
(D) Precursor frequency of self-specific lympho-
cytes that recognized gp100, Fib, or PPins in
males (n = 17) and females (n = 9) (see also Fig-
ure S2).
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Pre-existing Memory-Phenotype T Cells
To broadly survey antigen-specific CD4+ T cells, we selected
self-peptides from gp100, fibrinogen (Fib), or preproinsulin
(PPins) for their relevance in antitumor responses and autoim-
munity (Nielen et al., 2005; Yuan et al., 2009; Zhang et al.,
2008). Foreign antigens from gag p24 from HIV-1, pp65 from
CMV, and VP16 from HSV were selected because highly sensi-
tive serologic tests are available for clearly distinguishing
exposed individuals from unexposed individuals. The sensitivity
of the HSV, HIV, and CMV serologic tests are 97%–100%, and
with respect to HIV, the risk of a false negative is estimated to
be less than 1 in 2.6 million blood donations nationwide (Lack-
ritz et al., 1995). We also examined several epitopes from the
influenza virus and tetanus toxin, to which most people have
been exposed. Specific epitopes from each protein were
chosen from the literature on the basis of T cell stimulation
and evidence that they are the product of natural processing
and presentation (Alexander et al., 2010; Arif et al., 2004; Auger
et al., 2005; Bronke et al., 2005; Diethelm-Okita et al., 1997;
Lamb et al., 1982; Norris et al., 2004; Novak et al., 2001;
Phan et al., 2003).
We made tetramers by using peptide exchange to examine
antigen-specific CD4+ T cells from 26 HLA-DR4+ healthy blood
donors (Figure S2). We found that the frequency of precursor
cells recognizing a self-antigen or an unexposed viral epitope
generally ranged from one to ten cells per million CD4+ T cells
(Figure 2A). Notably, we found that previous exposure did not
necessarily result in a detectable expansion of cells specific to
that antigen, as shown by the similarity in the frequencies of
HSV-specific T cells between seropositive individuals and those
who are HSV negative. These data, as well as large interindi-
vidual differences in T cells recognizing the two dominant fluepitopes (HA and PB1), highlight the heterogeneity of a T cell
response in humans. Another notable feature in these data is
the absence of a statistically significant difference between the
frequencies of cells that recognize self-antigens (PPins, Fib, or
gp100) and those that bind to a naı¨ve foreign antigen from
HIV-1, CMV, or HSV in uninfected individuals (Figure 2B). These
self-antigen-specific T cells were examined for potential age- or
gender-dependent change, particularly because the risk of
autoimmunity is generally higher in the elderly and in females.
Although we did not detect significantly more gp100-, Fib-, or
PPins-specific T cells in older individuals (Figure 2C), we did
note a gender-specific difference—there were 1.7-fold more
gp100-, PPins-, and Fib-specific lymphocytes in females than
in males (Figure 2D).
The absence of an obvious frequency difference between
self- and foreign-antigen-specific populations suggests that
negative selection is incomplete for the particular self-specific-
ities examined. Alternatively, postthymic antigen stimulation
might have resulted in expansion of certain populations that
masked a difference in their initial frequencies. To assess the
latter, we analyzed the memory versus naı¨ve phenotype of these
tetramer-positive cells by using the classical memory marker
CD45RO (Appay et al., 2008). Unexpectedly, we found an abun-
dance of HIV-1-, CMV-, and HSV-specific memory-phenotype
T cells in individuals who were seronegative for those viruses
(Figure 3A). The fraction of these memory-phenotype T cells
ranged from 12% to 93% between different individuals, and
the average exceeded 50% (Figures 3B and 3C). These
memory-phenotype T cells positively correlate with T cell
frequency (Figure 3D) and have similar frequencies of central
memory-phenotype cells by chemokine receptor CCR7 ex-
pression as influenza-specific T cells (Appay et al., 2008)
(Figure S3).Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc. 375
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Figure 3. Characterization of the Memory
Phenotype in the CD4+ T Cell Repertoire
(A) Representative HA- and HIV-1-tetramer
labeling (left) and CD45RO-antibody staining
(right). Plots are representative of 15 individuals.
(B) Percentage of CD45RO+ memory cells within
each tetramer-tagged population. Each symbol
represents an antigen-specific population from
one individual, and the bar indicates the mean of
experiments performed independently with blood
obtained at different times.
(C) The percentage of memory phenotype among
T cells recognizing a novel foreign antigen (pre:
HIV-1, CMV, and HSV-naı¨ve), exposed foreign
antigen (post: Flu, tetanus, and HSV-exposed),
and self antigen (self: Fib, gp100, and PPins). The
figure summarizes data from all 26 individuals.
(D) Correlation plot combining all antigen-specific
populations from all donors. The total cell fre-
quency positively correlates with memory marker
expression. Statistical analysis was performed
with Spearman’s rank correlation. Regression
was performed by a least-squares fit (see also
Figure S3).
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Donors Have the Typical Properties of Memory T Cells
Wealso askedwhether these specificmemory-phenotype T cells
from unexposed individuals had known properties of functional
memory cells. First, we examined their cytokine responses
because memory cells are known to produce cytokines more
rapidly and in larger amounts than naı¨ve T cells (Mascher et al.,
1999). T cells labeled with the HIV-1 tetramers were identified
from healthy seronegative blood donors. Stimulation of these
cells for 3 hr by phorbol myristate acetate (PMA) and ionomycin
showed rapid IFN-g production by the CD45RO+ cells but much
less IFN-g production by the CD45RO T cells. This was compa-
rable to the influenza-specific T cells tested in parallel (Figure 4A).
Second, we performed gene expression analysis for tran-
scripts previously identified as being preferentially expressed
in memory and naı¨ve human CD4+ T cell populations (Haining
et al., 2008; Weng et al., 2012). Of the ten genes analyzed for
differential gene expression, five (ANXA1, CCR6, S100A4, FAS,
and SATB1) were statistically different between the CD45RO+
and CD45RO HIV-1-specific lymphocytes (Figure 4B). Analysis
of individual cells also showed that memory-phenotype cells
generally exhibited similar transcriptional patterns irrespective
of tetramer staining (Figure S4A).376 Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc.To examine the TCR repertoire of
memory-phenotype T cells, we sorted
CD45RO+ and CD45RO HIV-1-tet-
ramer-labeled cells individually and per-
formed TCR beta-chain amplification
and sequence analysis on each cell. A
total of 112HIV-1-specific CD45RO+ cells
and 82 HIV-1-specific CD45RO cells
from five HIV-negative individuals were
analyzed. For HIV-1-specific memory
cells, evidence of clonal expansion was
observed in four out of five blood donors,and 15%–50% of these cells from each donor had the exact
same TCR sequence as that of another cell from the same
person. In contrast, each TCR sequence was unique in HIV-1-
specific naı¨ve T cells. Similarly, T cell clonality was also observed
for HSV-specific memory T cells for two out of four donors and in
all three donors for HA-specific memory T cells (Figure 4C). The
extent of clonal expansion appeared less restricted for HIV-1-
specific T cells, which hadmore diverse Vb gene usage than cells
recognizing HA (Figure S4B).
Memory-Phenotype T Cells Are Largely Absent in
Umbilical Cord Blood
We also analyzed umbilical cord blood to examinewhether these
memory-phenotype cells are present at birth. Although the prev-
alence of a naı¨ve phenotype in bulk cord blood T cells versus
those in adults is well known (Cossarizza et al., 1996), the
frequency and phenotype of individual TCR specificities are
not. Two HLA-DR4+ human umbilical cord blood samples were
identified, and the characteristics of HIV-1-specific T cells
were analyzed and compared to those of adult blood cells. In
these samples, we found no apparent difference in the frequen-
cies of HIV-1-specific T cells, which were 3.6 and 8.2 per million
in the cord blood and were within 1 SD of the average of 4 per
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Figure 4. Memory-Phenotype T Cells in
Adults Have the Typical Memory Features
and Are Absent from Cord Blood
(A) Contour plots showing IFN-g response of HIV-
1- and PB1-specific T cells to stimulation by PMA
and ionomycin. Experiments were repeated twice
with blood from two different individuals.
(B) Gene expression of tetramer-negative and
HIV-1-tetramer-labeled cells. Forty-eight tetra-
mer-negative memory cells (TetNeg mem), 46
tetramer-negative naive cells (TetNeg naive), 53
HIV-1-specific memory cells (HIV Tet+ mem), and
52 HIV-1-specific naive cells (HIV Tet+ naive) were
analyzed. The heatmap summarizes the fraction of
cells expressing a particular gene out of the total
number of cells assayed. The genes have been
grouped by whether they associate with memory
(top) or naı¨ve (bottom) T cells and then ordered by
ascending p values, which compare the differ-
ences between HIV memory and HIV naı¨ve T cells.
(C)TCRbsequencingof tetramer-labeledCD45RO+
andCD45RO cells. Eachpie chart representsTCR
sequences from one individual. Dark-gray color
represents the fraction of cells expressing a TCR
identical to that of another cell. Light-gray color
represents cells expressing unique TCRs. HIV-1-
and HSV-specific T cells were obtained from indi-
viduals negative for these infections.
(D) HA- and HIV-1-specific T cells in adult PBMCs
(top) or cord blood (bottom) were identified
by tetramer staining followed by magnetic-bead
enrichment (left) and CD45RO-antibody surface
staining (right). Data are representative of two
adults PBMCs and two cord blood samples as-
sayed in parallel (see also Figure S4).
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CD4+ Memory-Phenotype T Cells in Unexposed Adultsmillion in adult samples (0–9.25) (Figure 4D). Similarly, T cells
recognizing the self-peptide from gp100 were also detectable
in cord blood cells at comparable frequencies (Figure S4C). In
contrast, CD45RO+ cells were strikingly absent from the
tetramer-positive T cells in the cord blood specimens (Figure 4DImmunity 38, 373–383,and Figure S4C). These findings indicate
that newborns possess a full complement
of T cells that can recognize self- and
foreign antigens, but the fact that essen-
tially all of the cells were naı¨ve suggests
that the memory-phenotype lymphocytes
described here are acquired sometime
after birth and before adulthood.
T Cells Selected for HIV-1
Specificity Can Recognize
Numerous Microbial Peptides
Because humans have copious exposure
to environmental antigens, we sought to
explore whether cross-reactivity to envi-
ronmental antigensmight have generated
these memory-phenotype T cells specific
to novel antigens. To evaluate the extent
of TCR cross-reactivity, we generated
24 HIV-1-specific clones by using blood
from three individuals by single-cell clon-ing of tetramer-positive cells as described previously in Fig-
ure 1B. Responsiveness to the HIV-1 antigen was demonstrated
by antigen stimulation with both the relevant peptide and the re-
combinant protein from which it is derived (Figures S5A and
S5B). Within the full-length HIV-1 peptide, there are two potentialFebruary 21, 2013 ª2013 Elsevier Inc. 377
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Figure 5. HIV-1-Specific T Cells Exhibit Extensive TCR Cross-reactivity
(A) Fluorescence-activated-cell-sorting plots of CFSE staining and cytokine production by a representative HIV-1-reactive clone (HIV clone 5). T cell proliferation
and cytokine production were observed in response to peptides derived from HIV-1, Micromonas, and B. bifidum, but not to an irrelevant HA peptide.
(B) Table summarizing peptide cross-reactivity for five HIV-1-specific clones that recognize alternate peptide sequences. The response of each clone to peptide
stimulation was repeated at least three times.
(C) Contour plots showing two cross-reactive clones that bind HIV-1 andR. flavefaciens tetramers (HIV clone 3) or HIV-1 andmicromonas tetramers (HIV clone 5),
but not HA tetramers. Data are representative of three independent experiments (see also Figure S5).
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CD4+ Memory-Phenotype T Cells in Unexposed Adultsregisters: HIV-1 167–179 was previously shown to bind a similar
DR allele (Zavala-Ruiz et al., 2004), and HIV-1 171–181 contains
the predicted anchor residues for HLA-DR4 (Hammer et al.,
1994; Sette et al., 1993; Southwood et al., 1998).We first showed
that both peptides stimulated different HIV-1-tetramer-labeled
clones (Figure S5C), and we then used these to identify similar
sequences with BLAST. In total, 24 sequences were examined
for cross-reactivity. Whether HIV-1-reactive clones become
stimulated by these peptides was determined by IFN-g and
interleukin-2 cytokine production and was validated by the
induction of cellular proliferation using carboxyfluorescein diac-
etate succinimidyl ester (CFSE). We found that TCR reactivity
was quite common and that 21% (5/24) of the clones responded
to at least two of these cross-reactive ligands (Figures 5A and 5B
and Figure S5D). The sources of peptides included bacteria from378 Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc.the gut and soil, other bacteria, and ocean algae and plants.
Notably, these peptides not only stimulated HIV-1-reactive
clones to produce cytokines and proliferate, but some also
probably had high TCR avidity and could bind by tetramers
(Figure 5C). Together, these data show that similar peptides in
microbial genomes can trigger HIV-1-specific responses.
Flu-Specific T Cells Recognize Other Microbial Peptides
In order to study cross-reactive T cell response to a known
antigen exposure, we recruited two individuals who had not
had flu vaccines for at least 5 years to receive the 2011 sea-
sonal influenza vaccine containing A/California/7/2009 (H1N1).
Response to vaccination was validated by an increase in the
influenza antibody to a protective titer of at least 1:40 (Figure 6A).
To analyze the corresponding T cell response, we examined ten
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Figure 6. Antigen-Specific T Cell Response to the 2009 H1N1
Vaccine
(A) Antibody response to A/California/7/2009 (H1N1) virus by hemagglutination
inhibition assay (HAI) titer at various time points before and after influenza
vaccination.
(B) Contour plot showing expansion of HA(H1N1)-specific T cells of donor 1 on
day 9 after vaccination.
(C) The kinetics of HA(H1N1)-specific T cells. Error bars represent the SEM.
Experiments from each donor at each time point were performed one to four
times, depending on sample availability.
(D) The percentage of HA(H1N1)-specific CD45RO+ T cells.
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CD4+ Memory-Phenotype T Cells in Unexposed AdultsHA specificities and found cells recognizing HA amino acids
391–410 to be highly expanded after immunization. The T cell
response to this epitope was tracked by HLA-DR4 tetramers
loaded with HA 391–410 peptide (HA(H1N1)) and appeared as
early as day 5 in the second donor when his hemagglutination
inhibition assay (HAI) titer was still undetectable (Figures 6B
and 6C). In both individuals, a dominant population of memory-
phenotype T cells specific to HA 391–410 was already present
prior to vaccination, consistent with conservation of this peptide
in other influenza strains (Figure 6D).
To evaluate T cell cross-reactivity, we cloned HA(H1N1)-
specific T cells from postvaccination blood samples and
assayed them for their response to other microbial peptides
identified by an approach similar to that for HIV-1-specific
T cells. T cell stimulation by these peptides demonstrated that
HA(H1N1)-specific T cell clones responded specifically to the
HA 391–410 peptide sequence by which they were isolated
and to peptides from F. magna (1352 hypothetical protein 131–
143) and T. vaginalis (TVAG_489980 hypothetical protein 118–
130), but not to an irrelevant HIV-1 peptide (Figure 7A). Although
the cross-reactive peptides were quite similar to the HA core
sequence (HA 398-410) and also to each other, these peptides
differed from HA 398–410 in their ability to stimulate HA-reactive
clones and elicited distinct responses in the two donors (Fig-
ure 7B and Figure S6). Differences in the fine specificities to
these peptides were further evident by tetramer labeling, which
showed that F. magna and T. vaginalis peptides bound different
HA(H1N1)-specific T cell clones with distinct avidity (Figure 7C).We further demonstrated that flu vaccination induced expan-
sion of cross-reactive T cells in vivo. A previously undetectable
cell population that was labeled with both influenza and
F. magna tetramers and that consisted entirely of memory-
phenotype cells was observed after vaccination (Figure 7D).
The extent of this cross-reactive T cell expansion was transient
and followed a very similar trajectory to that of the HA(H1N1)-
specific population (Figure 7E). By day 49, the frequency of
F. magna cross-reactive T cells was down to 5.9 cells per million,
a frequency previously considered to be for naı¨ve T cells. Expan-
sion of cross-reactive T cells was also observed in the second
donor (Figures S7A and S7B): the fraction of cross-reactive
T cells accounted for 14% and 4% of total HA(H1N1) reactive
T cells in donors 1 and 2, respectively (Figure S7C). Together,
these experiments directly show that immunization with one
microbe can give rise to T cells specific to another cross-reactive
specificity.
DISCUSSION
The work of Jenkins and colleagues has shown that, with the use
of a combination of peptide-MHC tetramer staining and enrich-
ment, it is possible to directly study the preimmune repertoire
of ab T cells in mice (Moon et al., 2007). Here, we have extended
these studies to the analysis of CD4+ T cells in human peripheral
blood to characterize the T cell precursor frequency and pheno-
type. Examination of a variety of human class II MHC-restricted
self- and non-self-epitopes revealed that most specificities
range in frequency from one to ten per million CD4+ T cells.
Very recent work measuring the frequency of precursor cells
recognizing Bacillus anthracis found a similar frequency range
(Kwok et al., 2012). The data described here represent a compre-
hensive analysis of the human CD4+ T cell repertoire and include
multiple self- and microbial antigens from different organisms in
adults and compare the frequency and phenotype of some of
these in newborns. They show that despite the fact that humans
have a 1,0003 greater number of T cells than do mice, their
ligand repertoire for CD4+ T cells is very similar to that of mice.
This larger human TCR repertoire relative to that of mice
suggests that humans might have a greater degree of redun-
dancy in the numbers of TCRs that can recognize the same
antigen. In agreement with this conclusion, we found here that
TCRs specific to a particular HIV-1 peptide or HLA-DR4 ligand
encompass a large number of different TCR sequences. In addi-
tion to the repertoire composition, analysis of the antigen-
specific T cells by enrichment of peptide-MHC tetramers
revealed an intriguing 1.7-fold increase in autoantigen-specific
T cells in females compared to males. Although speculative,
a gender disparity in the number of autoreactive T cells might
help to explain why autoimmunity is often more prevalent in
females.
Arguably the most intriguing finding from this characterization
of human T cell precursors is the abundance of memory-pheno-
type T cells in healthy adults for foreign antigens that those indi-
viduals have never encountered. These CD45RO+ CD4+ T cells
exhibited rapid IFN-g production, evidence of clonal expansion,
and the preferential expression of transcripts associated with
memory T cells. Previous studies in murine CD8+ T cells
have also found a memory-phenotype population in precursorImmunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc. 379
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Figure 7. T Cells Responsive to Flu Vaccination Also Cross-recognized Microbial Peptides
(A) CFSE staining of a representative HA(H1N1)-specific clone that proliferated in response to HA 391–410 peptide and also to peptides derived from F. magna
and T. vaginalis, but not to a control HIV-1 peptide. T cell stimulation with each peptide was repeated at least three times.
(B) Table showing the sequences of full-length HA 391–410 peptide, HA 398–410 core sequence, F. magna peptide, and T. vaginalis peptide. Twenty-one clones
from donor 1 and 12 clones from donor 2 were combined and assayed for response to each peptide. Data are representative of two independent experiments.
(C) Tetramer labeling of two HA(H1N1)-reactive clones by HA(H1N1), F. magna, and T. vaginalis tetramers. The experiment was repeated two times.
(D) Direct ex vivo analysis of HA(H1N1)- and F. magna-tetramer-positive cells. A population of influenza and F. magna cross-reactive (F. magna cx) cells became
detectable on day 9 and exhibited 100% memory phenotype.
(E) Frequencies of the total HA(H1N1)-tetramer-positive cells and cross-reactive T cells colabeled with F. magna tetramers (F. magna cx). Error bars represent the
SEM. Experiments at each time point were performed one to three times, depending on sample availability (see also Figures S6 and S7).
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CD4+ Memory-Phenotype T Cells in Unexposed AdultsT cells (Sprent and Surh, 2011). Because memory-phenotype
T cells have also been found in germ-free mice, they are thought
to have arisen through homeostatic proliferation driven by self-
antigen interactions (Haluszczak et al., 2009). Antigen-specific
precursor memory cells have subsequently been found in other
mouse studies and have been shown to be generated in the
periphery during neonatal lymphopenia and to thereafter be
stably maintained and increase with age (Akue et al., 2012; Dec-
man et al., 2012; Rudd et al., 2011). For CD4+ T cells, homeo-
static proliferation also induces memory-phenotype T cells in
lymphopenic animals (Min et al., 2004), but CD4+ T cells appear
to be less sensitive to homeostatic signals and differ from CD8+
T cells in their TCR-dependent lipid-raft regulation and response
to IL-7 signaling (Cho et al., 2010; Guimond et al., 2009). Studies
on precursor CD4+ T cells in immunocompetent mice have
generally found these cells to have a naı¨ve phenotype (Chu
et al., 2010; Moon et al., 2007). In humans, homeostatic prolifer-
ation maintains the peripheral naı¨ve T cell pool in adults (den
Braber et al., 2012), but whether or not a portion of the T cells380 Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc.undergoing homeostatic cell turnover can develop a memory
phenotype in a healthy human is not known.
Given these caveats on how homeostatic proliferation might
pertain to CD4+ T cells in healthy adults and also given that
humans are exposed to copious environmental antigens, we
sought to investigate an alternate mechanism whereby these
memory-phenotype cells are generated by cross-reactivity
with environmental antigens. Unlike CD8+ T cells that interact
mostly with endogenous antigens, CD4+ T cells, by virtue of
being restricted to professional antigen-presenting cells that
engulf and sample external antigens, are intrinsically predis-
posed to respond to changes in the environment. Moreover,
there is a clear tendency on the part of at least some TCRs to
recognize distinctly different peptide-MHC combinations,
thereby enabling the same T cell to be activated by different
ligands. Cross-reactive TCRs have been implicated in the path-
ogenesis of a number of autoimmune diseases (Benoist and
Mathis, 2001) and have been proposed to explain why sequential
infections in mice result in differences in immune pathology and
Immunity
CD4+ Memory-Phenotype T Cells in Unexposed Adultsthe hierarchy of immunodominance (Welsh et al., 2010). In
humans, there is also a growing recognition that vaccinations
and their sequence of exposure can have a more general impact
on morbidity and mortality beyond the expected benefit in pre-
venting the targeted disease (Shann et al., 2010). For example,
several large retrospective and longitudinal studies on young
children have found a survival benefit from measles vaccines
even when death from measles was excluded (Kristensen
et al., 2000; Veirum et al., 2005). Consistent with these observa-
tions is the result of a randomized control trial involving over
6,000 children; it also showed a vaccine-dependent mortality
reduction that was independent of measles-related death
(Aaby et al., 2010). The dose and sequence of immunization
appear to matter, and children given diphtheria-tetanus-
pertussis (DTP) vaccine after being immunized for measles
have an increased risk of death and hospitalization, particularly
if a high-titer measles vaccine is used (Aaby et al., 2003). In light
of the data presented here, it seems possible that these broader
vaccine effects might be mediated by cross-reactive T cell
memory. The paucity of these cross-reactive cells could also
help to explain why very young children are more susceptible
to infectious diseases than are older ones (Casanova and Abel,
2005; Moore et al., 1999), and whether these responses are
generated could mean the difference between survival and
death.
In agreement with the relevance of cross-reactivity, we have
shown here that this is not a rare phenomenon. Of the 24 HIV-
1-reactive T cell clones analyzed, 21% had the ability to recog-
nize multiple alternate ligands from environmental sources.
Although it is also possible that our data reflect a potential bias
of repertoires selected on the HLA-DR4 allele, this is still almost
certainly an underestimate of the extent of cross-reactivity given
that the propensity of T cells to cross-react with very different
peptide sequences is well known and is probably directly
enabled by the flexibility of the TCR binding site (Newell et al.,
2011; Reinherz et al., 1999; Reiser et al., 2003). To directly test
the hypothesis that CD4+ T cells can become activated and
acquire a memory phenotype through cross-reactive interac-
tions, we vaccinated two individuals with the seasonal flu
vaccine containing the influenza virus A/California/7/2009
(H1N1). We showed that T cells specific to both an HA epitope
and a related sequence from F. magna, a human commensal
bacteria (Levy et al., 2009), are both stimulated to proliferate
and have the typical rise and fall of tetramer-positive T cells after
vaccination. We also detected donor-specific differences in that
one donor’s cells responded to both F. magna and a second
cross-reactive epitope from T. vaginalis, a common sexually
transmitted infection (Johnston and Mabey, 2008). This directly
shows that exposure to one microbe is able to stimulate immune
cells specific to cross-reactive peptides from very different
microbes. We postulate that differences in microbial exposure
and subsequent T cell cross-reactivity might help to explain
some of the large variation in how individuals respond to infec-
tious diseases. Our findings complement the existing data on
homeostatic mechanisms of memory induction and provide
a basis for further investigations on how environmental exposure
might shape one’s immune repertoire.
In summary, our analysis of the human CD4+ T cell repertoire
has uncovered a number of findings but especially that healthyadults have numerous memory cells specific to foreign antigens
to which they have never been exposed. Our data argue for TCR
cross-reactivity in the acquisition of these cells and demonstrate
interindividual differences in this response. Regardless of the
mechanism, these memory-phenotype T cells specific to novel
pathogens might confer an advantage for survival against infec-
tions. Individual differences in cross-reactive T cell memory
might further explain the heterogeneity of response to infections
in humans.
EXPERIMENTAL PROCEDURES
Human Subjects
PBMCs were obtained from the Stanford Blood Bank. Cells in deidentified leu-
koreduction chambers from healthy platelet donors were processed as soon
as possible and no later than 18 hr after plateletpheresis. For analysis of
precursor T cells, an experiment used at least 30 million CD4+ T cells and typi-
cally between 50 and 150 million CD4+ T cells. For the flu-vaccination study,
two healthy adults were recruited to receive the 2011 seasonal influenza vacci-
nation. Details on the donor viral testing and vaccine-study recruitment and
sample processing are described in the Supplemental Experimental Proce-
dures. Recruitment of study subjects was conducted in accordance with the
rules and regulations of the Stanford institutional review board.
Identification and Analysis of Antigen-Specific T Cells
PBMCs were enriched with CD4+ cells by Rosettasep and ficoll centrifugation
(STEMCELL Technologies). Tetramer staining was carried out at room temper-
ature for 1 hrwith 10 ug/ml tetramers in thepresence of purified anti-CD16, anti-
CD32, and non-CD4 exclusion markers. Cells were incubated for an additional
10 min at room temperature with Agua live-dead dye, anti-CD4, anti-CD45RO,
and anti-CCR7 for memory phenotyping. Tetramer-tagged cells were enriched
by theadditionof anti-PEand/or anti-APCmagneticbeadsandbybeingpassed
throughamagnetizedcolumn (Miltenyi). Sampleswereanalyzedbyflowcytom-
etry with LSRII (Becton Dickinson) and FlowJo software (Tree Star). Cells were
stimulated immediately after isolation with PMA and ionomycin for cytokine
analysis, sorted according to CD45RO expression for gene expression and
TCR sequencing, or cultured individually for the generation of antigen-specific
clones. In brief, for cytokine analysis, cells were stimulated with PMA
(150 ng/ml) and ionomycin (1 mM) for 3 hr and assayed for intracellular IL2
and IFN-g production in the presence of protein-transport inhibitor. Multiplex
real-time PCR and gene expression analysis were performed with TaqMan
Gene Expression primers (Applied Biosystems) and the BioMark system
(Fluidgm). TCR sequences from single cells were obtained by a series of
three nested PCR reactions. For the generation of antigen-specific clones,
tetramer-labeled cells were sorted individually and expanded by PHA and IL2.
See the Supplemental Experimental Procedures for the list of antibodies and
tetramers and also for detailed descriptions of frequency and sensitivity calcu-
lation, gene expression analysis, TCR sequencing, and cloning procedure.
Statistics
For analysis of experiments comparing a single variable, statistical signifi-
cance was analyzed with a Student’s t test. Spearman rank correlation and
least-squares fit regression were applied for measuring the degree of associ-
ation. A p value < 0.05 was used as a cutoff for statistical significance. Differ-
ential gene expression was analyzed by a two-sided Mann-Whitney test and
corrected for multiple-hypothesis testing with the use of false-discovery rates
(Benjamini and Hochberg). Genes were considered to be significantly differen-
tially expressed between groups if they had p values and false discovery
rates < 0.05. All data analysis was performed with R statistical package
v.2.13 and GraphPad Prism.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2012.10.021.Immunity 38, 373–383, February 21, 2013 ª2013 Elsevier Inc. 381
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